• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC RA LEAD; PERMANENT PACEMAKER ELECTRODE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC RA LEAD; PERMANENT PACEMAKER ELECTRODE Back to Search Results
Model Number 5076
Device Problems Over-Sensing (1438); Ambient Noise Problem (2877)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
It was reported that this right atrial (ra) lead and the right ventricular (rv) lead, underwent a system revision due to oversensed noise on both channels.Pacing inhibition with creator than 2 seconds of asystole was observed.It was noted that this pacemaker was implanted subcutaneously.The leads were tested on the pacing system analyzer (psa), however the reported noise was not reproducible and lead measurements were within normal limits.The leads were surgically abandoned and replaced.No additional adverse patient effects were reported.This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RA LEAD
Type of Device
PERMANENT PACEMAKER ELECTRODE
Manufacturer (Section D)
MEDTRONIC
MDR Report Key17489439
MDR Text Key320699557
Report NumberMW5121984
Device Sequence Number1
Product Code DTB
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 02/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Model Number5076
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/09/2023
Patient Sequence Number1
-
-